These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9635826)

  • 1. Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research.
    Fitzpatrick R; Davies L
    Br J Cancer; 1998 May; 77(10):1543-8. PubMed ID: 9635826
    [No Abstract]   [Full Text] [Related]  

  • 2. American Cancer Society and Roche Laboratories Interactive Workshop on Medical Ethics Versus Medical Economics: A Health Care Dilemma in Cancer Patient Care. Proceedings. Washington, D.C., February 16-17, 1993.
    Cancer; 1993 Nov; 72(9 Suppl):2795-864. PubMed ID: 8104683
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 4. Three questions about costs and cancer clinical trials.
    Chirikos TN
    Cancer Control; 2003; 10(1):71-8. PubMed ID: 12598857
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient costs on clinical trials.
    Presant CA
    J Natl Cancer Inst; 2000 Sep; 92(17):1441-3. PubMed ID: 10974083
    [No Abstract]   [Full Text] [Related]  

  • 6. Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research.
    Smyth JF; Mossman J; Hall R; Hepburn S; Pinkerton R; Richards M; Thatcher N; Box J
    BMJ; 1994 Aug; 309(6952):457-61. PubMed ID: 7920132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cancer education mission: managed care and clinical trials.
    Raich PC; Morton N
    J Cancer Educ; 1999; 14(2):93-5. PubMed ID: 10397484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taking quality of life into account in health economic analyses.
    Weeks J
    J Natl Cancer Inst Monogr; 1996; (20):23-7. PubMed ID: 8750463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More states mandate coverage of clinical trial costs, but does it make a difference?
    McBride G
    J Natl Cancer Inst; 2003 Sep; 95(17):1268-9. PubMed ID: 12953076
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare to cover routine care costs in clinical trials.
    Arnold K; Vastag B
    J Natl Cancer Inst; 2000 Jul; 92(13):1032. PubMed ID: 10880539
    [No Abstract]   [Full Text] [Related]  

  • 11. What's cost-effective in cancer care?
    Cancer Discov; 2011 Nov; 1(6):OF1-2. PubMed ID: 22586658
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop.
    Neymark N; Kiebert W; Torfs K; Davies L; Fayers P; Hillner B; Gelber R; Guyatt G; Kind P; Machin D; Nord E; Osoba D; Revicki D; Schulman K; Simpson K
    Eur J Cancer; 1998 Aug; 34(9):1317-33. PubMed ID: 9849412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wanted: senior citizens for cancer treatment trials.
    Benowitz S
    J Natl Cancer Inst; 2000 Mar; 92(6):446-7. PubMed ID: 10716958
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic analyses in clinical trials for cooperative groups: operational considerations.
    Bennett CL; Waters TM
    Cancer Invest; 1997; 15(5):448-53. PubMed ID: 9316627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental treatment costs in national cancer institute-sponsored clinical trials.
    Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
    JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Strategy Group workshop. Improvements in patient access to new anti-cancer medicines.
    Br J Cancer; 1999 Jan; 79(1):2-3. PubMed ID: 10408683
    [No Abstract]   [Full Text] [Related]  

  • 17. The economic evaluation of cancer treatments and programmes.
    Goddard M; Drummond M
    Eur J Cancer; 1991; 27(10):1191-6. PubMed ID: 1835583
    [No Abstract]   [Full Text] [Related]  

  • 18. Costs studies show clinical trials, standard therapy may be equal.
    Reynolds T
    J Natl Cancer Inst; 2000 Jul; 92(14):1116-8. PubMed ID: 10904079
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer patient care in clinical trials sponsored by the National Cancer Institute: what does it cost?
    Brown ML
    J Natl Cancer Inst; 1999 May; 91(10):818-9. PubMed ID: 10340896
    [No Abstract]   [Full Text] [Related]  

  • 20. Costs of quality-of-life research in Southwest Oncology Group trials.
    Moinpour CM
    J Natl Cancer Inst Monogr; 1996; (20):11-6. PubMed ID: 8750461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.